Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response
Michelle von Locquenghien, Catalina Rozalén, Toni Celià-Terrassa
Journal of Clinical Investigation (2021) Vol. 131, Iss. 1
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer
Shanshan Jiang, Yile Xie, Xiuying Xiao, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 5, pp. 781-797.e9
Open Access | Times Cited: 145
Polysaccharide-based nanomedicines for cancer immunotherapy: A review
Yujun Zeng, Yufan Xiang, Ruilong Sheng, et al.
Bioactive Materials (2021) Vol. 6, Iss. 10, pp. 3358-3382
Open Access | Times Cited: 121
Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
Lu Tang, Zhongpei Huang, Heng Mei, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Cancer cell-intrinsic mechanisms driving acquired immune tolerance
Ehsan Ghorani, Charles Swanton, Sergio A. Quezada
Immunity (2023) Vol. 56, Iss. 10, pp. 2270-2295
Open Access | Times Cited: 50
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Shaochuan Liu, Qian Sun, Xiubao Ren
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 49
Dysregulation in IFN-γ signaling and response: the barricade to tumor immunotherapy
Jiashu Han, Mengwei Wu, Ziwen Liu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 42
Cancer stem cell mimicry for immune evasion and therapeutic resistance
Phei Er Saw, Qiang Liu, Ping‐Pui Wong, et al.
Cell stem cell (2024) Vol. 31, Iss. 8, pp. 1101-1112
Closed Access | Times Cited: 30
Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche
Jayanta Mondal, Junfeng Zhang, Qing Feng, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer
Iván Pérez-Núñez, Catalina Rozalén, José Ángel Palomeque, et al.
Nature Cancer (2022) Vol. 3, Iss. 3, pp. 355-370
Open Access | Times Cited: 42
Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma
Xiang Wang, Chunliang Liu, Jianan Chen, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 39
Escape from T-cell–targeting immunotherapies in acute myeloid leukemia
Jayakumar Vadakekolathu, Sergio Rutella
Blood (2023) Vol. 143, Iss. 26, pp. 2689-2700
Open Access | Times Cited: 31
Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer
Kexun Zhou, Shuo Li, Yi Zhao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma
Gang Ji, Qi Yang, Song Wang, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities
Jessica Konen, Haoyi Wu, Don L. Gibbons
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 520-536
Closed Access | Times Cited: 9
STING in Cancer Immunoediting: Modeling Tumor-Immune Dynamics Throughout Cancer Development
Xiao Zhang, Yan Chen, Xi Liu, et al.
Cancer Letters (2025) Vol. 612, pp. 217410-217410
Open Access | Times Cited: 1
Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation
Weiyuan Wang, Melanie Cristina Lopez McDonald, Rajashree Hariprasad, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1387-1387
Open Access | Times Cited: 7
Current landscape and perspective of oncolytic viruses and their combination therapies
Yinghan Su, Changqing Su, Lun‐Xiu Qin
Translational Oncology (2022) Vol. 25, pp. 101530-101530
Open Access | Times Cited: 25
An anti-cancer surveillance by the interplay between interferon-beta and retinoblastoma protein RB1
Albert Qin
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense
Ling Wang, Shunbin Ning
Viruses (2021) Vol. 13, Iss. 2, pp. 279-279
Open Access | Times Cited: 29
Systemic Delivery of mPEG‐Masked Trispecific T‐Cell Nanoengagers in Synergy with STING Agonists Overcomes Immunotherapy Resistance in TNBC and Generates a Vaccination Effect
Ming Shen, Chuanrong Chen, Qianqian Guo, et al.
Advanced Science (2022) Vol. 9, Iss. 32
Open Access | Times Cited: 21
Cell Therapy as Target Therapy against Colon Cancer Stem Cells
Elsa N. Garza-Treviño, Adriana G. Quiroz-Reyes, Juan Antonio Rojas Murillo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8163-8163
Open Access | Times Cited: 11
CircSOBP suppresses the progression of glioma by disrupting glycolysis and promoting the MDA5-mediated immune response
Maolin Mu, Wanxiang Niu, Fang Chu, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107897-107897
Open Access | Times Cited: 11
Oral reovirus reshapes the gut microbiome and enhances antitumor immunity in colon cancer
Won Suk Lee, Seung Joon Lee, Hye Jin Lee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
CRY1 fuels resistance to T cell-based immunotherapy in NANOGhigh cancers
Tae Woo Kim, Se Jin Oh, Seon Rang Woo, et al.
Research Square (Research Square) (2025)
Closed Access
The Dynamic Role of Ferroptosis in Cancer Immunoediting: Implications for Immunotherapy
Jun Lan, Dan Cai, Shuang Gou, et al.
Pharmacological Research (2025) Vol. 214, pp. 107674-107674
Open Access
Page 1 - Next Page

Scroll to top